41 related articles for article (PubMed ID: 22158493)
1. Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas.
Watson J; Romagna A; Ballhausen H; Niyazi M; Lietke S; Siller S; Belka C; Thon N; Nachbichler SB
Radiat Oncol; 2020 Dec; 15(1):275. PubMed ID: 33298103
[TBL] [Abstract][Full Text] [Related]
2. Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: Initial clinical experience.
Kutuk T; Tolakanahalli R; Chaswal V; Yarlagadda S; Herrera R; Appel H; La Rosa A; Mishra V; Wieczorek DJJ; McDermott MW; Siomin V; Mehta MP; Odia Y; Gutierrez AN; Kotecha R
Brachytherapy; 2023; 22(6):872-881. PubMed ID: 37722990
[TBL] [Abstract][Full Text] [Related]
3. Epithelioid glioblastoma diagnosed 70 years after craniofacial radiotherapy.
Bugdadi A; Cherif MA; Loganadane G; Brugières P; Marniche A; Itti E; Belkacemi Y; Tauziède-Espariat A; Palfi S; Senova S
Acta Neurochir (Wien); 2023 Oct; 165(10):2769-2774. PubMed ID: 37269332
[TBL] [Abstract][Full Text] [Related]
4. Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomas.
Harari CM; Burr AR; Morris BA; Tomé WA; Bayliss A; Bhatia A; Grogan PT; Robins HI; Howard SP
Neurooncol Adv; 2024; 6(1):vdae073. PubMed ID: 38845694
[TBL] [Abstract][Full Text] [Related]
5. Re-Irradiation Using Brachytherapy for Recurrent Intracranial Tumors: A Systematic Review and Meta-Analysis of the Literature.
Choi M; Zabramski JM
Cureus; 2020 Aug; 12(8):e9666. PubMed ID: 32923261
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging classification of progression patterns in glioblastoma: a systematic review.
Piper RJ; Senthil KK; Yan JL; Price SJ
J Neurooncol; 2018 Aug; 139(1):77-88. PubMed ID: 29603080
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
Straube C; Scherb H; Gempt J; Kirschke J; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
BMC Cancer; 2018 Jan; 18(1):15. PubMed ID: 29298660
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Adult Brain Tumor Consortium (ABTC) prospective dose-finding trials of I-125 balloon brachytherapy in high-grade gliomas: challenges in clinical trial design and technology development when MRI treatment effect and recurrence appear similar.
Kleinberg LR; Stieber V; Mikkelsen T; Judy K; Weingart J; Barnett G; Olson J; Desideri S; Ye X; Grossman S
J Radiat Oncol; 2015 Sep; 4(3):235-241. PubMed ID: 27695605
[TBL] [Abstract][Full Text] [Related]
9. Intracavitary moderator balloon combined with (252)Cf brachytherapy and boron neutron capture therapy, improving dosimetry in brain tumour and infiltrations.
Brandão SF; Campos TP
Br J Radiol; 2015 Jul; 88(1051):20140829. PubMed ID: 25927876
[TBL] [Abstract][Full Text] [Related]
10. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL; Fisher JD; Carson K; Grossman SA;
J Neurosurg; 2003 Aug; 99(2):297-303. PubMed ID: 12924704
[TBL] [Abstract][Full Text] [Related]
11. Interstitial brachytherapy procedures for brain tumors.
Sneed PK; McDermott MW; Gutin PH
Semin Surg Oncol; 1997; 13(3):157-66. PubMed ID: 9143053
[TBL] [Abstract][Full Text] [Related]
12. [Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].
Boisserie G; Cornu P; Dormont D; Sahel M; Hardiman C; Tep B; Mandin AM; Barret C; Faillot T; Delattre JY; Monjour A; Poisson M; Marsault C; Philippon J; Simon JM; Baillet F; Mazeron JJ
Bull Cancer Radiother; 1996; 83(3):144-52. PubMed ID: 8977564
[TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.
Gobitti C; Borsatti E; Arcicasa M; Roncadin M; Franchin G; Minatel E; Skrap M; Zanotti B; Tuniz F; Cimitan M; Capra E; Drigo A; Trovò MG
Tumori; 2011; 97(5):614-9. PubMed ID: 22158493
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
15. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
Gabayan AJ; Green SB; Sanan A; Jenrette J; Schultz C; Papagikos M; Tatter SP; Patel A; Amin P; Lustig R; Bastin KT; Watson G; Burri S; Stea B
Neurosurgery; 2006 Apr; 58(4):701-9; discussion 701-9. PubMed ID: 16575334
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
